Non-Current Assets
Intangible Assets Gross (Excluding Goodwill)
Vertex Pharmaceuticals Intangible Assets Gross (Excluding Goodwill) remained flat by 0.0% to $470.30M in Q3 2025 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ4 2015
Last reportedQ3 2025
How to read this metric
Growth suggests successful acquisition of intellectual property or investment in proprietary technology platforms.
Detailed definition
This is the total cost of identifiable intangible assets such as patents, trademarks, and software, excluding goodwill....
Peer comparison
Common for technology, financial services, and brand-heavy companies.
Metric ID:
intangible_assets_gross_excluding_goodwillHistorical Data
4 periods
| Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|
| Value | $849.30M | $470.30M | $470.30M | $470.30M |
| QoQ Change | — | -44.6% | +0.0% | +0.0% |
Range$470.30M – $849.30M
Current Streak2 quarters growth
Intangible Assets Gross (Excluding Goodwill) at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's intangible assets gross (excluding goodwill)?
- Vertex Pharmaceuticals (VRTX) reported intangible assets gross (excluding goodwill) of $470.30M in Q3 2025.
- What does intangible assets gross (excluding goodwill) mean?
- The total cost of non-physical assets like patents and software, excluding goodwill.